Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark G Torchia

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
The Journal of Biocommunication|June 29, 2002
Lymph node. EvaluationBill Peters, Mark G Torchia
AJR. American Journal of Roentgenology|November 20, 2002
Combined MR lymphangiography and MR imaging-guided needle localization of sentinel lymph nodes using Gadomer-17Mark G Torchia, Bernd Misselwitz
Head & Neck|February 9, 2005
Dynamic MR lymphangiography and carbon dye for sentinel lymph node detection: a solution for sentinel lymph node biopsy in mucosal head and neck cancerRichard W Nason, Mark G Torchia, Carmen M Morales, et al.
Journal of Neurosurgery|April 9, 2013
Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical articleAndrew E Sloan, Manmeet S Ahluwalia, Jose Valerio-Pascua, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
The Journal of Biocommunication|June 29, 2002
Lymph node. EvaluationBill Peters, Mark G Torchia
AJR. American Journal of Roentgenology|November 20, 2002
Combined MR lymphangiography and MR imaging-guided needle localization of sentinel lymph nodes using Gadomer-17Mark G Torchia, Bernd Misselwitz
Head & Neck|February 9, 2005
Dynamic MR lymphangiography and carbon dye for sentinel lymph node detection: a solution for sentinel lymph node biopsy in mucosal head and neck cancerRichard W Nason, Mark G Torchia, Carmen M Morales, et al.
Journal of Neurosurgery|April 9, 2013
Results of the NeuroBlate System first-in-humans Phase I clinical trial for recurrent glioblastoma: clinical articleAndrew E Sloan, Manmeet S Ahluwalia, Jose Valerio-Pascua, et al.
Pageof 1